---
figid: PMC8235637__ijms-22-06467-g003
figtitle: Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human
  Renal Cell Carcinoma Cells
organisms:
- Homo sapiens
- Mus musculus
- Candida dubliniensis
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC8235637
filename: ijms-22-06467-g003.jpg
figlink: /pmc/articles/PMC8235637/figure/ijms-22-06467-f003/
number: F3
caption: 'Cellular changes induced through chronic treatment with sunitinib resulting
  in sunitinib resistance. Schematic representation of induced cellular changes in
  response to sunitinib treatment, mainly focusing on autophagy, chemotaxis and stereoisomerisation
  after lysosomal accumulation. Sunitinib inhibits the signal transduction via Akt/mTOR,
  Ras/MAPK and PKC through binding to the ATP-binding site of numerous cell membrane
  receptors, i.e., PDGFR, c-KIT, FLT-3, RET, VEGFR. Lysosomal accumulation: Lysosomes
  store sunitinib, where the acidic pH inhibits the reconversion from (E) to (Z).
  Cells might have intrinsic selectivity to stereoisomers, which could be linked to
  efflux. Lysosomal storage further induces autophagy by dysregulating autophagy-related
  proteins, i.e., LAMP, LAMTOR, MAPK and MTOR activator and LC3. Lysophatidic acid:
  Sunitinib treatment induces the production of lysophatidic acid, which binds to
  lysophosphatidic acid receptors (LAPR) that are linked to G-protein signaling. Dependent
  on the subsequent signaling pathway, cellular functions, i.e., cytoskeleton remodeling,
  adherens junction assembly, angiogenesis-influencing proteins and chemotaxis, will
  be downregulated. Legend: ATP = adenosine triphosphate; CD36 = integral membrane
  protein; c-Src = protein kinase; FAK = focal adhesion kinase; FKHR = Forkhead box
  protein O1 (FOXO1); FLT3 = fms like tyrosine kinase 3; GSK3 = serine/threonine protein
  kinase (Glycogen synthase kinase 3); HDAC = histone deacetylase; KIT = tyrosine
  kinase; LAMP = lysosome associated membrane protein; LAMTOR = endosomal/lysosomal
  adaptor and mitogen activated protein kinase; LAPR = lysophosphatidic acid receptor;
  MAPK = mitogen activated protein kinase; PDGFR = platelet derived growth factor
  receptor; LC3 = light chain 3; PKC = protein kinase C; PRKD = serine/threonine protein
  kinase; RET = tyrosine protein kinase receptor; RhoA = Ras homolog family member
  A; Tiam = T-lymphoma invasion and metastasis-inducing protein 1; VEGFR = vascular
  endothelial GFR.'
papertitle: Molecular and Functional Analysis of Sunitinib-Resistance Induction in
  Human Renal Cell Carcinoma Cells.
reftext: Magdalena Rausch, et al. Int J Mol Sci. 2021 Jun;22(12):6467.
year: '2021'
doi: 10.3390/ijms22126467
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: acquired drug resistance | (clear cell) renal cell carcinoma | drug combination
  | isomerization | metabolites | sunitinib
automl_pathway: 0.9002756
figid_alias: PMC8235637__F3
figtype: Figure
redirect_from: /figures/PMC8235637__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8235637__ijms-22-06467-g003.html
  '@type': Dataset
  description: 'Cellular changes induced through chronic treatment with sunitinib
    resulting in sunitinib resistance. Schematic representation of induced cellular
    changes in response to sunitinib treatment, mainly focusing on autophagy, chemotaxis
    and stereoisomerisation after lysosomal accumulation. Sunitinib inhibits the signal
    transduction via Akt/mTOR, Ras/MAPK and PKC through binding to the ATP-binding
    site of numerous cell membrane receptors, i.e., PDGFR, c-KIT, FLT-3, RET, VEGFR.
    Lysosomal accumulation: Lysosomes store sunitinib, where the acidic pH inhibits
    the reconversion from (E) to (Z). Cells might have intrinsic selectivity to stereoisomers,
    which could be linked to efflux. Lysosomal storage further induces autophagy by
    dysregulating autophagy-related proteins, i.e., LAMP, LAMTOR, MAPK and MTOR activator
    and LC3. Lysophatidic acid: Sunitinib treatment induces the production of lysophatidic
    acid, which binds to lysophosphatidic acid receptors (LAPR) that are linked to
    G-protein signaling. Dependent on the subsequent signaling pathway, cellular functions,
    i.e., cytoskeleton remodeling, adherens junction assembly, angiogenesis-influencing
    proteins and chemotaxis, will be downregulated. Legend: ATP = adenosine triphosphate;
    CD36 = integral membrane protein; c-Src = protein kinase; FAK = focal adhesion
    kinase; FKHR = Forkhead box protein O1 (FOXO1); FLT3 = fms like tyrosine kinase
    3; GSK3 = serine/threonine protein kinase (Glycogen synthase kinase 3); HDAC =
    histone deacetylase; KIT = tyrosine kinase; LAMP = lysosome associated membrane
    protein; LAMTOR = endosomal/lysosomal adaptor and mitogen activated protein kinase;
    LAPR = lysophosphatidic acid receptor; MAPK = mitogen activated protein kinase;
    PDGFR = platelet derived growth factor receptor; LC3 = light chain 3; PKC = protein
    kinase C; PRKD = serine/threonine protein kinase; RET = tyrosine protein kinase
    receptor; RhoA = Ras homolog family member A; Tiam = T-lymphoma invasion and metastasis-inducing
    protein 1; VEGFR = vascular endothelial GFR.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lamp1
  - Lamp2
  - Map1lc3a
  - Pdgfrb
  - Kit
  - Flt3
  - Ret
  - Akt1
  - Mtor
  - ras
  - Hras
  - Kras
  - Rem1
  - Lpar1
  - Rhoa
  - Lpar2
  - Src
  - Lpar3
  - Gsk3b
  - Lpar4
  - Ctnnb1
  - Cdh1
  - Fzr1
  - Hdac7
  - Foxo1
  - Cd36
  - Scarb1
  - LAMP1
  - LAMP2
  - ATP8A2
  - MAP1LC3A
  - PDGFRB
  - PDGFRA
  - KIT
  - FLT3
  - RET
  - KDR
  - FLT1
  - FLT4
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - KRAS
  - HRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - LPAR1
  - RHOA
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - IGKV2D-19
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - LPAR2
  - SRC
  - PTK2
  - LPAR3
  - GSK3A
  - GSK3B
  - LPAR4
  - CTNNB1
  - CDH1
  - FZR1
  - TIAM1
  - TIAM2
  - HDAC7
  - HDAC9
  - FOXO1
  - CD36
  - lamp1b
  - lamp2
  - b3gnt5a
  - kita
  - flt3
  - ret
  - mtor
  - rab1ab
  - lpar1
  - rhoaa
  - rhoab
  - olfcg6
  - src
  - ngfra
  - lpar3
  - gsk3ba
  - gsk3ab
  - lpar4
  - ctnnb1
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - hdac7b
  - hdac7a
  - foxo3b
  - cd36
---
